Skip to main content
  • American Heart Association
  • Science Volunteer
  • Warning Signs
  • Advanced Search
  • Donate

  • Home
  • About this Journal
    • Editorial Board
    • General Statistics
    • Circulation Doodle
      • Doodle Gallery
      • Circulation Cover Doodle
        • → Blip the Doodle
    • Information for Advertisers
    • Author Reprints
    • Commercial Reprints
    • Customer Service and Ordering Information
    • Subscribe to AHA Journals
  • All Issues
  • Subjects
    • All Subjects
    • Arrhythmia and Electrophysiology
    • Basic, Translational, and Clinical Research
    • Critical Care and Resuscitation
    • Epidemiology, Lifestyle, and Prevention
    • Genetics
    • Heart Failure and Cardiac Disease
    • Hypertension
    • Imaging and Diagnostic Testing
    • Intervention, Surgery, Transplantation
    • Quality and Outcomes
    • Stroke
    • Vascular Disease
  • Browse Features
    • AHA Guidelines and Statements
      • Recently Published Guidelines
    • Bridging Disciplines
    • → Articles Bridging Discplines
    • Go Red for Women Issue
    • Cardiovascular Case Series
    • Circulation at ESC
    • Circulation at AHA Scientific Sessions
    • Global Impact of the 2017 ACC/AHA Hypertension Guidelines
    • Circulation at ACC 2018
    • Circulation Supplements
    • ECG Challenge
    • Hospitals of History
      • Brigham and Women's Hospital
      • Hartford Hospital
      • Hospital Santa Maria del Popolo, Naples, Italy
      • Instituto do Coração-INCOR (São Paulo, Brasil)
      • Minneapolis City Hospital
      • Parkland Hospital: Dallas, Texas
      • Pennsylvania Hospital, Philadelphia
      • Pitié-Salpêtrière Hospital
      • Royal Infirmary of Edinburgh, Scotland
      • Tufts Medical Center
      • University of Michigan
      • Uppsala University Hospital
      • Vassar Brothers Medical Center (Poughkeepsie, NY)
      • Wroclaw Medical University
      • Women's College Hospital, Toronto, Canada
      • Henry Ford Hospital, Detroit, Michigan
      • Instituto Nacional de Cardiología Ignacio Chávez – INCICh México City, México
      • Kuang-Tien General Hospital (Taichug, Taiwan)
    • On My Mind
    • Podcast Archive
    • → Subscribe to Circulation on the Run
    • →Circulation FIT Podcast 2018
    • → #FITFAVs
  • Resources
    • Instructions for Authors
      • Accepted Manuscripts
      • Revised Manuscripts
    • → Article Types
    • → General Preparation Instructions
    • → Research Guidelines
    • → How to Submit a Manuscript
    • Journal Policies
    • Permissions and Rights Q&A
    • Submission Sites
    • Circulation CME
    • AHA Journals RSS Feeds
    • International Users
    • AHA Newsroom
  • AHA Journals
    • AHA Journals Home
    • Arteriosclerosis, Thrombosis, and Vascular Biology (ATVB)
    • Circulation
    • → Circ: Arrhythmia and Electrophysiology
    • → Circ: Genomic and Precision Medicine
    • → Circ: Cardiovascular Imaging
    • → Circ: Cardiovascular Interventions
    • → Circ: Cardiovascular Quality & Outcomes
    • → Circ: Heart Failure
    • Circulation Research
    • Hypertension
    • Stroke
    • Journal of the American Heart Association
  • Facebook
  • Twitter

  • My alerts
  • Sign In
  • Join

  • Advanced search

Header Publisher Menu

  • American Heart Association
  • Science Volunteer
  • Warning Signs
  • Advanced Search
  • Donate

Circulation

  • My alerts
  • Sign In
  • Join

  • Facebook
  • Twitter
  • Home
  • About this Journal
    • Editorial Board
    • General Statistics
    • Circulation Doodle
    • Information for Advertisers
    • Author Reprints
    • Commercial Reprints
    • Customer Service and Ordering Information
    • Subscribe to AHA Journals
  • All Issues
  • Subjects
    • All Subjects
    • Arrhythmia and Electrophysiology
    • Basic, Translational, and Clinical Research
    • Critical Care and Resuscitation
    • Epidemiology, Lifestyle, and Prevention
    • Genetics
    • Heart Failure and Cardiac Disease
    • Hypertension
    • Imaging and Diagnostic Testing
    • Intervention, Surgery, Transplantation
    • Quality and Outcomes
    • Stroke
    • Vascular Disease
  • Browse Features
    • AHA Guidelines and Statements
    • Bridging Disciplines
    • → Articles Bridging Discplines
    • Go Red for Women Issue
    • Cardiovascular Case Series
    • Circulation at ESC
    • Circulation at AHA Scientific Sessions
    • Global Impact of the 2017 ACC/AHA Hypertension Guidelines
    • Circulation at ACC 2018
    • Circulation Supplements
    • ECG Challenge
    • Hospitals of History
    • On My Mind
    • Podcast Archive
    • → Subscribe to Circulation on the Run
    • →Circulation FIT Podcast 2018
    • → #FITFAVs
  • Resources
    • Instructions for Authors
    • → Article Types
    • → General Preparation Instructions
    • → Research Guidelines
    • → How to Submit a Manuscript
    • Journal Policies
    • Permissions and Rights Q&A
    • Submission Sites
    • Circulation CME
    • AHA Journals RSS Feeds
    • International Users
    • AHA Newsroom
  • AHA Journals
    • AHA Journals Home
    • Arteriosclerosis, Thrombosis, and Vascular Biology (ATVB)
    • Circulation
    • → Circ: Arrhythmia and Electrophysiology
    • → Circ: Genomic and Precision Medicine
    • → Circ: Cardiovascular Imaging
    • → Circ: Cardiovascular Interventions
    • → Circ: Cardiovascular Quality & Outcomes
    • → Circ: Heart Failure
    • Circulation Research
    • Hypertension
    • Stroke
    • Journal of the American Heart Association
Contemporary Reviews in Cardiovascular Medicine

Neurocardiogenic Syncope and Related Disorders of Orthostatic Intolerance

Blair P. Grubb
Download PDF
https://doi.org/10.1161/CIRCULATIONAHA.104.482018
Circulation. 2005;111:2997-3006
Originally published June 6, 2005
Blair P. Grubb
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Tables
  • Info & Metrics
  • eLetters

Jump to

  • Article
    • Autonomic Nervous System
    • Summary
    • References
  • Figures & Tables
  • Info & Metrics
  • eLetters
Loading
  • nervous system, autonomic
  • syncope
  • hypotension, orthostatic

Received September 14, 2004; revision received January 31, 2005; accepted March 9, 2005.

“We shall not cease from exploration and the end of all our exploring will be to arrive where we started and know the place for the first time” — —T.S. Eliot, Four Quartets

Syncope, defined as transient loss of consciousness and postural tone with spontaneous recovery, has both challenged and perplexed physicians since the dawn of recorded time. The earliest written accounts come from Hippocrates, and the word syncope itself is derived from an old Greek term meaning “to cut short” or “interrupt.” Recurrent episodes of syncope may result from a large number of different disorders, all of which cause a transitory reduction in cerebral blood flow sufficient to disturb the normal functions of the brain. Over the last 2 decades, considerable attention has been given to types of syncope that occur due to a centrally mediated (or “reflex”) fall in systemic blood pressure, a condition that has been referred to as vasovagal (and later neurocardiogenic) syncope. However, research into the nature of this disorder revealed that it is but one aspect of a broad and varied group of disturbances in the normal functioning of the autonomic nervous system (ANS), each of which may result in orthostatic intolerance, hypotension, and ultimately syncope. Continued investigations into the nature of these similar yet different disorders has led to the development of a system of classification that attempts to more accurately reflect our understanding of these conditions and their interrelationships.1

The present system of classification has proven both functional and clinically relevant and includes a group of disorders that most investigators have thought to be principally autonomic in nature. Because both the cardiologist and the cardiac electrophysiologist frequently are expected to both diagnose and treat these conditions, the following review is designed to provide a basic framework for understanding their causes, clinical presentations, diagnosis, and management.

Autonomic Nervous System

To survive in the world, all animals must possess the ability to make moment by moment alterations that permit their internal environment to remain stable despite dramatic changes in their external environment. This includes not only changes in ambient temperature, humidity, and barometric pressure but also the ability to react quickly to the presence of perceived danger. The principal neural mechanisms by which this “homeostasis” is maintained and regulated are governed by the hypothalamus via its 2 effector systems, which include the ANS and the endocrine system.2

Although the adoption of upright posture represents one of the defining moments in human development, it nonetheless provided a unique challenge to a blood pressure control system that had principally evolved to meet the needs of animals who spent the majority of their time in a dorsal position.1–4 The ANS provides the principal means for both the short- and long-term responses to changes in position (the renin-angiotensin-aldosterone system also plays a role but over a longer time frame).5 In the normal person, approximately 25% to 30% of blood volume is located in the thorax when they are supine. On standing, there is a gravity-mediated downward displacement of roughly 300 to 800 mL of blood to the vasculature of the abdomen and lower extremities.6 This represents a volume drop of between 25% and 30%, half of which occurs within the first few minutes of standing. This sudden redistribution of blood results in a fall in venous return to the heart. Because the heart can only pump the blood that it receives, this causes a fall in stroke volume of ≈40% and a decline in arterial pressure. The reference point around which these changes occur is called the venous hydrostatic indifference point (HIP) and is defined as the site in the vascular system where pressure is independent of posture (the venous HIP is around the diaphragm, the arterial HIP is near the level of the left ventricle).5 Compared with the arterial HIP, the venous HIP is dynamic in nature and is influenced by factors such as the degree of vascular compliance, intravascular volume, and muscular activity. While standing, contractions of the leg muscles (in conjunction with the venous valve system) actively pump blood back to the heart and move the venous HIP closer to the level of the right atrium.

In addition, standing produces a substantial increase in the transmural capillary pressure present in the dependent areas of the body, which causes a rise in fluid filtration into tissue spaces. This process reaches a steady state after ≈30 minutes of upright posture and can produce a decline in plasma volume of up to 10%.

Successful maintenance of upright posture (and cerebral perfusion) requires the interplay of several cardiovascular regulatory systems. Orthostatic stabilization occurs within 1 minute. The exact response to postural change differs with standing (an active process) compared with responses seen during head-up tilt (a more passive process). Wieling and van Lieshout7 have described 3 phases of orthostatic response. These consist of (1) the initial response (during the first 30 seconds), (2) the early steady state alteration (at 1 to 2 minutes), and finally (3) the prolonged orthostatic period (after at least 5 minutes upright).7

Immediately after head-up tilt, cardiac stroke volume remains normal despite the decline in venous return (believed to occur due to blood left in the pulmonary circulation). This is followed by a gradual fall in both arterial pressure and cardiac filling. This causes activation of 2 different groups of pressure receptors consisting of the high-pressure receptors of the carotid sinus and aortic arch and the low-pressure receptors of the heart and lungs.5 Within the heart, there are mechanoreceptors linked by unmyelinated vagal afferents in all 4 cardiac chambers. These mechanoreceptors produce a tonic inhibitory effect on the cardiovascular control centers of the medulla, in particular on the nucleus tractus solitarii. The baroreceptive neurons of the nucleus tractus solitarii directly activate cardiovagal neurons of the nucleus ambiguous and dorsal vagal nucleus while inhibiting the sympathoexcitatory neurons of the rostral ventrolateral medulla.3

The reduced venous return and fall in filling pressure that occur during upright posture reduce the stretch on these receptors. As their firing rates decrease, there is a change in medullary input, which triggers an increase in sympathetic outflow. This causes a constriction not only of the systemic resistance vessels but of the splanchnic capacitance vessels as well. In addition, there is a focal axon reflex (the venoarteriolar axon reflex) that can constrict flow to the skin, muscle, and adipose tissue. This may contribute up to 50% of the increase in limb vascular resistance seen during upright posture.7

During head-up tilt, there is also activation of the high-pressure receptors in the carotid sinus. The carotid sinus contains a group of baroreceptors and nerve endings located in the enlarged area of the internal carotid artery, just after its origin from the common carotid artery. Here, the mechanoreceptors are located in the adventitia of the arterial wall.8 The afferent impulses generated by stretch on the arterial wall are then transmitted via the sensory fibers of the carotid sinus nerve that travels with the glossopharyngeal nerve. These afferent pathways terminate in the nucleus tractus solitarii in the medulla, near the dorsal and ambiguous nuclei.4 The initial increase in heart rate seen during tilt is thought to be modulated by a decline in carotid artery pressure. The slow rise in diastolic pressure seen during upright tilt is believed to be more closely related to a progressive increase in peripheral vascular resistance.

The circulatory changes seen during standing are somewhat different from those seen during tilt. Standing is a much more active process that is accompanied by contractions of muscles of both the leg and abdomen, which produces a compression of both capacitance and resistance vessels and results in an elevation in peripheral vascular resistance. This increase is sufficient to cause a transient increase in both right atrial pressure and cardiac output, which in turn causes an activation of the low-pressure receptors of the heart. This provokes an increase in neural traffic to the brain, with a subsequent decrease in peripheral vascular resistance, which can fall as much as 40%.6 This can allow a fall in mean arterial pressure of up to 20 mm Hg that can last for up to 6 to 8 seconds. The decline in pressure is then compensated for by the same mechanisms as during head-up tilt.

The early steady state adjustments to upright posture consist of an increase in heart ate of ≈10 to 15 bpm, an increase of ≈10 mm Hg, and little or no change in systolic blood pressure.7 At this point, compared with supine posture, the blood volume of the thorax has fallen by 30%, cardiac output has increased by 30%, and heart rate is 10 to 15 bpm higher.5

Continued upright posture also activates a series of neurohormonal changes, the exact extent of which depend on the patient’s volume status. The greater the volume depletion, the greater the degree of activation of the renin-angiotensin-aldosterone system (and vasopressin). However, one of the most important aspects of the body’s ability to compensate for continued orthostatic stress is the influence of arterial baroreceptors (particularly the carotid sinus) on peripheral vascular resistance. At any given moment, ≈5% of the body’s blood is in the capillaries, 8% is in the heart, 12% is in the pulmonary vasculature, 15% is in the arterial system, and 60% is in the venous system.6 The inability of any one of these mechanisms to operate adequately (or in a coordinated manner) may result in a failure of the body to compensate to either an initial or prolonged orthostatic challenge. This, in turn, would result in systemic hypotension, which, if sufficiently profound, could lead to cerebral hypoperfusion and subsequent loss of consciousness.

Conditions That Occur as a Result of Disturbances in Orthostatic Control

A growing number of autonomic disturbances of orthostatic regulation have been identified. Although in many ways similar, each has features that make it unique. In attempting to classify them into a useful system, one should remember that when we look at nature, in many ways we see what we wish to see that fits what we know about it at that moment. Conditions such as supraventricular tachycardia and long-QT syndrome were each first thought to be a single entity but with time were found to be composed of a variety of subgroups. To attempt to make sense of the apparent chaos of nature, we try to organize and classify it into a coherent framework and system that fits with both our knowledge and our expectations.9 Thus, any system of classification is in many ways arbitrary, subject to debate, and in a constant process of revision and refinement. The system presented in the Figure follows that developed by the American Autonomic Society and attempts to represent our current understanding of these disorders in a clinically useful framework.10 In some ways, all autonomic disturbances can be thought of as being either primary or secondary in origin. The primary forms tend to be idiopathic, unassociated with other diseases, and are either acute or chronic in nature. Conversely, the secondary forms are seen in conjunction with another disease process (such as diabetes and amyloidosis) or alternatively occur owing to a known biochemical or structural deficiency or after exposure to known toxic agents (such as alcohol and heavy metals). A brief description of each subtype follows, along with references for the reader who desires a more in-depth discussion.

Figure1
  • Download figure
  • Open in new tab
  • Download powerpoint

Disorders of ANS associated with orthostatic intolerance.

Reflex Syncopes

The reflex syncopes are a group of disorders that occur because of a sudden failure of the ANS to maintain adequate vascular tone during orthostatic stress, resulting in hypotension (frequently associated with bradycardia) that results in cerebral hypoperfusion and loss of consciousness. The 2 most frequent types of reflex syncope are neurocardiogenic (vasovagal) syncope and carotid sinus syndrome. The other types of reflex syncopes are often referred to as situational because they are often associated with specific activities or conditions. Neurocardiogenic syncope (NCS) can be quite varied in presentation.11 It tends to occur in younger patients and tends to exhibit 3 distinct phases that consist of a distinct prodrome (usually lightheadedness, nausea, diaphoresis, or visual changes) followed by a sudden loss of consciousness. Recovery is usually quite rapid, and postictal states are rare. However, nearly one third of patients (most commonly older adults) will experience few, if any, prodromal symptoms, and loss of consciousness occurs suddenly, with little warning. The cause of neurocardiogenic syncope is unclear. It can be brought on by pain, emotional distress, or by prolonged standing (especially in very warm environments), yet many episodes occur without any specific provocation. Although still the subject of considerable debate, it is presently believed that the pathophysiology of NCS often is related to prolonged orthostatic stress.12 This results in an increased amount of peripheral venous pooling to a point great enough that the venous return to the heart falls so precipitously that a significant increase in ventricular inotropy occurs. This hypercontractile state is believed to activate mechanoreceptors that would normally fire only during stretch.13 The sudden increase in neural traffic to the medulla is thought to mimic the conditions seen in hypertension, thus causing an apparent “paradoxic” decline in sympathetic activity that results in hypotension, bradycardia, and ultimately syncope.14 It should be remembered, however, that other stimuli (for example fear, strong emotion, or epileptic discharges) can elicit nearly identical responses, which raises the possibility that these patients may have an inherent susceptibility to these events. During head-upright tilt-table testing, these individuals will demonstrate a relatively sudden fall in blood pressure that is often (but not always) followed by a decline in heart rate (sometimes to the point of asystole).

Sutton and Peterson15 have noted that there is a striking similarity between the hemodynamic collapse profile seen during NCS and carotid sinus syndrome, which suggests that they may be different aspects of the same underlying condition. Indeed, it has been postulated that all the reflex syncopes occur in susceptible individuals when sudden activation of mechanoreceptors from any site (rectum, esophagus, bladder, or cough) produces a similar response. Recent studies on defecation syncope have supported this concept. What distinguishes the reflex syncopes from the other conditions discussed herein is that between episodes of syncope, these patients complain of few (if any) autonomic symptoms. Thus, in this group, the autonomic system appears to function in a relatively normal manner, despite being somewhat “hypersensitive,” as opposed to other conditions in which the autonomic system appears to “fail,” functioning at a level inadequate for the body’s needs, which results in varying degrees of orthostatic intolerance.11

Primary Autonomic Failure: Chronic Forms

The first of the autonomic failure syndromes described was by Bradbury and Eggleston in 1925.16 They used the phrase “idiopathic orthostatic hypotension” to describe the condition because of its apparent lack of other features; however, this term does not adequately describe the generalized state of autonomic failure that occurs in these patients, characterized by disturbed bowel, bladder, sudomotor, thermoregulatory, and sexual function (without somatic involvement). At present, the condition is referred to as pure autonomic failure (PAF).17 PAF usually begins between ages 50 and 70 years, and it displays a 2:1 male-to-female ratio.18 Symptoms are slow and insidious in onset, usually beginning with vague complaints of orthostatic weakness, dizziness, and lightheadedness that are often dismissed by physicians as insignificant.19 As their orthostatic hypotension worsens, patients experience near syncope or syncope, which often prompts the patient to seek initial medical attention. In men, the earliest symptoms are impotence and loss of libido, whereas in women, urinary retention and incontinence occur first. This condition is characterized by orthostatic hypotension, syncope or near syncope, constipation, urinary retention, inability to sweat, and impotence.20 Although PAF may lead to severe functional impairment, only rarely is it fatal.

A second, much more severe form of autonomic failure (associated with somatic defects) was subsequently described by Shy and Drager in 1960.21 As opposed to the situation in PAF, these patents not only have severe orthostatic hypotension but also have iris atrophy, urinary and rectal incontinence, loss of sweating, external ocular palsy, rigidity, tremor, and impotence. The condition is now referred to as multiple system atrophy (MSA) and usually begins in the fifth to sixth decade of life (although the disorder may occasionally begin in the late 30s or early 40s), with men affected twice as often as women.18 As in PAF, syncope and near syncope are the symptoms that most frequently prompt the patient to seek medical attention. Although MSA patients may start with symptoms that suggest PAF, they later begin to develop symptoms of somatic nervous system involvement, in addition to central nervous system involvement.22 Indeed, MSA is divided into 3 different subtypes depending on the somatic system involved.18,19 The first group displays a motor tremor similar to that seen in Parkinson’s disease (some authors refer to this group as having striatonigral degeneration on the basis of autopsy findings).23

In contrast to true Parkinson’s disease, there tends to be more rigidity than tremor, yet the rigidity lacks the typical “cogwheel” or “lead pipe” rigidity seen in Parkinson’s disease.24,25 Patients with parkinsonian-type MSA frequently display a loss of facial expression and limb akinesia. The second subtype of MSA is characterized by prominent cerebellar and/or pyramidal features (also called olivopontocerebellar atrophy/degenerative form on the basis of autopsy findings).26 These patients have a significant gait disturbance and truncal ataxia that may impede the person from standing without support. Slurring of speech and loss of diction are common, as is a mild intention tremor of the extremities. The third group of MSA patients displays a combination of parkinsonian and cerebellar features and are referred to as having “mixed” MSA.22 A recent autopsy study reported that between 7% and 22% of patients diagnosed with Parkinson’s disease during life were found to have neuropathologic changes diagnostic for MSA after death.24 The natural history of MSA is one of relentless progression after onset, with most patients dying within 5 to 8 years after onset (although rarely, individuals have survived up to 20 years). Apnea, aspiration, and respiratory failure are the most frequent causes of death.19

Over the last decade, considerable attention has been given to a relatively new subgroup of disorders currently referred to as the postural tachycardia syndrome (POTS). This appears to be a milder, less severe form of autonomic insufficiency that is characterized by excessive increases in heart rate while in the upright position.27 There are 2 primary forms of the disorder that have been identified. The more common variety is referred to as the peripheral (or partial) dysautonomic form.28 The hallmark of this group is a persistent tachycardia while upright, which can achieve rates of 160 bpm or higher, that typically is associated with complaints of severe fatigue, exercise intolerance, palpitations, near syncope, lightheadedness, and dizziness. Many patients also complain of cognitive impairment and visual disturbances and of intolerance to the heat while at the same time always feeling cold. During tilt-table testing, they will display a significant increase in heart rate of >30 bpm in the first 10 minutes or will achieve a maximum heart rate of >120 bpm over the same time frame, often associated with only a modest decline in blood pressure.29 The pathophysiology appears to be a failure of peripheral vascular resistance to increase adequately in the face of orthostatic stress. This results in excessive blood pooling in the dependent areas of the body, which is then compensated for by an increase in heart rate and inotropy. Investigators have reported that in some patients, POTS may be the earliest sign of autonomic dysfunction and that occasional patients (≤10%) may later progress to PAF. Onset may occur after a viral infection, trauma, or surgery or may be associated with the joint hypermobility syndrome.30

The second type of POTS is referred to as the “β-hypersensitivity” or “central” form. In this form, there is believed to be an inadequate feedback process that arises from above the level of the baroreflex.30 Although the initial heart rate responses to upright posture are adequate, the brain does not know when to stop the response, and heart rate continues to elevate. Some patients who have this form of POTS will demonstrate orthostatic hypertension and postural tachycardia. Although the clinical presentations of both groups are similar, the hyperadrenergic form is often associated with migraines, excess sweating, and tremor. Serum catecholamine levels are usually quite high (serum norepinephrine is often >600 ng/dL), and patients exhibit an excessive response to isoproterenol infusion (>30 bpm increase in response to 1 μg/min).27

Recent investigations have suggested a genetic basis for this group of disorders. A landmark study by Shannon et al31 has identified the exact genes responsible for this subgroup in 1 family with a number of severely affected members. The defect was in the genetic code for a protein responsible for recycling norepinephrine in the intrasynaptic cleft, which allowed for excessively high levels of serum norepinephrine. There may be multiple genetic forms of this disorder, and studies are under way to determine this.

Acute Autonomic Dysfunction

Although uncommon, the acute autonomic neuropathies are dramatic in presentation.32 Onset is quite sudden and is heralded by severe diffuse failure of both the parasympathetic and sympathetic systems, whereas the somatic system remains unaffected.33 Orthostatic hypotension is often so severe that sitting up in bed results in syncope. Complete loss of sweating and severe bowel and bladder dysfunction are common, causing nausea, abdominal pain, bloating, and vomiting.34 Heart rates drop to 45 to 55 bpm, with complete chronotropic incompetence. Recent studies completed by Verino et al35 have demonstrated that many of these patients have high levels of antibodies to acetylcholine receptors in the autonomic ganglia, which suggests that the disorder is autoimmune in nature.

Secondary Causes of Autonomic Dysfunction

There are a number of different disorders that may disturb normal autonomic function, and the interested reader is directed elsewhere.9 It is important to keep in mind that any autonomic disturbance may be part of a larger disease process (for example, malignancy). A number of different drugs may either cause or contribute to orthostatic hypotension (Table 1). Systemic illness that affects multiple organs (eg, cancer, diabetes mellitus, amyloidosis, and renal failure) may disturb autonomic function to a degree that orthostatic hypotension and syncope occur. Recent studies have demonstrated a link between orthostatic hypotension and Alzheimer’s disease.36 Orthostatic hypotension may also occur owing to single enzyme abnormalities. Examples include isolated dopamine B-hydroxylase deficiency and nerve growth factor deficiency.37

View this table:
  • View inline
  • View popup

TABLE 1. Pharmacological Agents That May Cause or Worsen Orthostatic Intolerance

Clinical Features

The main feature that is shared by each of these disorders is a disruption in cardiovascular regulation to such an extent that postural hypotension and/or tachycardia or bradycardia occurs. Historically, orthostatic hypotension has been described as a >20 mm Hg fall in systolic blood pressure or a >10 mm Hg fall in diastolic blood pressure over a 2-minute period after standing. Yet a less dramatic decline in blood pressure associated with symptoms may be equally important. Often, patients will display a gradual progressive decline in blood pressure over a more prolonged period of time (≈10 to 15 minutes) that will also result in symptoms. Whether symptoms occur will depend on the rate at which blood pressure falls and the total degree of change. The reflex syncopes tend to exhibit abrupt falls in blood pressure that are often associated with a definitive prodrome. In contrast, the loss of consciousness in the orthostatic (or “dysautonomic”) syncopes tends to be slow and gradual.37 This more gradual fall in blood pressure is often not perceived by a number of older patients, who often will report these episodes as “drop attacks” that occur with little warning. Those who do perceive the fall in blood pressure will relate feeling lightheaded, having blurred or tunnel vision, or having visual disturbances. One distinguishing factor between reflex and dysautonomic syncope is that the latter usually is not associated with diaphoresis and bradycardia.19 Dysautonomic syncopes tend to be more common in the morning after arising from sleep and are worsened by any condition that enhances peripheral venous pooling (eg, heat, alcohol, or fatigue). Patients with PAF and MSA may develop severe chronotropic incompetence with a relatively fixed heart rate (50 to 70 bpm).20 Some patients with significant autonomic dysfunction (particularly diabetes) may display a combination of upright hypotension and supine hypertension, which is believed to be due to an inability to adequately vasoconstrict when upright or vasodilate when prone.19 At times, it is difficult to fully distinguish between the various disorders, because a considerable degree of overlap may occur (not dissimilar to the situation seen in chronic obstructive pulmonary disease).

Diagnosis

The most important aspect of evaluation is a comprehensive history and physical examination. When did symptoms first appear? Is the main problem syncope, lightheadedness, or fatigue? When do symptoms tend to occur, and what factors make them worse or better? Are there other organ symptoms that appear to be involved? A detailed, careful history and physical examination will have a much greater yield than the indiscriminate ordering of multiple laboratory examinations. Indeed, testing should proceed in a prudent and directed fashion to evaluate the diagnosis suggested by the history and physical examination.

It is beyond the scope of this review to provide a detailed discussion of every autonomic disorder and the various laboratory tests used in their evaluation. The interested reader is referred to several excellent texts on the subject.2–4 Special attention should be given to identify any prescription or over-the-counter medications that could cause or exacerbate hypotension, as well as to recognize the possibility of illicit drug or alcohol abuse.

Because the autonomic centers of the brain are not readily accessible to direct measurement, autonomic function principally is evaluated by observing the responses of different functions or organ systems to a variety of pharmacological or physiological challenges.38 The simplest and most important of these is the recording of heart rate and blood pressure in the supine, sitting, and immediate upright positions, as well as at 3 and 5 minutes after being upright. Blood pressure measurements should be made with the arm extended horizontally (to minimize any hydrostatic effect produced by having the arm in a dependent position).18 Because the responses noted during standing differ from those seen during passive tilt, we often perform tilt-table testing on these patients. There is an extensive body of literature on tilt-table testing that is reviewed in detail elsewhere.39 There are other tests of autonomic function available that provide useful information in selected patients, the details of which are available elsewhere.11,38

Briefly, however, some aspects of tilt-table testing will be outlined. Tilt-table testing is based on the concept that an orthostatic stress, such as prolonged upright posture, could be used to cause venous pooling and thereby provoke the previously discussed responses in predisposed individuals.39 In contrast to standing, the patient is strapped to a table that is able to incline at an angle of 60° to 70° that serves to inhibit the skeletal muscle pump and thus force the autonomic system to function on its own. Deprived of a component of the compensatory mechanism that the person has come to depend on, abnormal hemodynamic and rate changes are more likely to be observed. At present, head-up tilt-table testing is the only diagnostic test for neurocardiogenic syncope to have been studied in detail. The specificity of tilt-table testing (without pharmacological challenge) is near 90% but is less with pharmacological provocation. The false-positive rate is 10%. Short-term (days to weeks) reproducibility of results is approximately 80% to 90%, whereas long-term reproducibility (>1 year) is ≈60%.38 Because there is no true “gold standard” against which to compare it, the exact sensitivity of tilt-table testing is unknown.39 The stress induced during tilt-table testing is different from that which the patient experiences clinically. The recent International Study of Syncope of Uncertain Etiology (ISSUE) that compared tilt-induced syncopal episodes with spontaneously recorded episodes (with an implantable loop recorder) showed that spontaneous events were more likely to be associated with significant bradycardia.40

Guidelines for tilt-table testing have been issued by the American College of Cardiology and the European Society of Cardiology.41,42 A list of indications for tilt-table testing is provided in Table 2. Although useful for diagnosis of NCS, tilt-table testing has not proved useful in determining the efficacy of therapy.41

View this table:
  • View inline
  • View popup

TABLE 2. Indications for Head-Up Tilt-Table Testing

Abnormal responses to tilt-table testing can be grouped into 5 basic types. The first of these is the classic neurocardiogenic (or vasovagal) response, which is characterized by a rapid drop in blood pressure (with or without associated bradycardia). The second pattern, which we have termed “dysautonomic,” demonstrates a gradual fall in blood pressure (with little change in heart rate) that ultimately results in loss of consciousness (usually seen in the autonomic failure syndromes). The third pattern, a postural tachycardia response, consists of a >30 bpm increase in heart rate (or a heart rate >120 bpm during the first 10 minutes of the baseline tilt). The fourth pattern we have called “cerebral syncope.”43 These individuals will experience syncope in the absence of systemic hypotension, associated with intense cerebral vasoconstriction (as measured by transcranial Doppler) and cerebral hypoxia (as measured by electroencephalogram). The last response is referred to as “psychogenic”; in this pattern, syncope occurs during tilt in the absence of hypotension or of any identifiable change in transcranial Doppler or electroencephalogram.44 These patients have been found to have psychiatric disorders ranging from conversion reactions to anxiety disorders and major depression.45 Individuals with conversion reactions are not consciously aware of their actions. A significant number of young people (especially women) with psychogenic syncope were found to have been victims of sexual abuse. Psychogenic syncope in the abused child or adolescent may represent a cry for help, a cry that should not fall on deaf ears.45

Tilt-table testing is not required in all patients. In some patients, a history compatible with neurocardiogenic syncope in the absence of another identifiable cause is sufficient to make the diagnosis; however, if any question exists as to the diagnosis, tilt-table testing can be used to help clarify the cause.

Therapeutic Modalities

A detailed discussion of all therapies used in the various types of autonomic dysfunction associated with orthostatic intolerance is beyond the scope of this review. The following review is brief, and more detailed discussions are available elsewhere.42

The first task of the clinician is to determine to the extent possible the type of autonomic disorder present. In addition, one must establish whether the disorder is primary or secondary in nature and identify any potentially reversible causes. It is equally important to educate the patient and family as to the nature of the disorder and counsel them to avoid any predisposing factors such as extreme heat and dehydration. Patients are encouraged to increase their fluid (and in some cases salt) intake and should be instructed to recognize potential warning signs of impending syncope and to take evasive actions (such as lying down).

Nonpharmacological treatments should be encouraged. Moderate aerobic and isometric exercise enhances peripheral muscle strength, thereby facilitating the ability of the skeletal muscle pump to augment venous return to the heart. Tilt training appears to be helpful in neurocardiogenic syncope; however, long-term compliance is poor.46–48 Sleeping with the head of the bed upright (≈6 inches) is useful in autonomic failure syndromes, as are elastic support hose that are at least waist high and provide a minimum of 30 mm Hg of ankle counterpressure. Isometric countermaneuvers, such as leg and arm muscle tensing, are useful in preventing neurocardiogenic syncope if used at the earliest sign of symptoms.49,50 Biofeedback therapy has also been helpful in preventing neurocardiogenic syncope induced by various psychological stimuli.

Despite all of the above measures, some patients will continue to be symptomatic. In the patient who has recurrent episodes of syncope (or near syncope) associated with injury or a high risk of injury (to themselves or others), prophylactic pharmacotherapy is indicated. In patients with very frequent or severe episodes of syncope (especially in those who have already sustained significant injury due to syncope-related falls), it is sometimes useful to initiate pharmacotherapy early in management to bring the episodes under control while waiting for more conservative measures to take effect. Any drug should be chosen carefully to fit the needs of each patient, not only with respect to the disorder being treated but also in relation to any concomitant conditions they may have or medications they may be taking. Any drug used to treat an autonomic disorder may, on occasion, worsen rather than lessen symptoms (a prosyncopal effect).

β-Blockers were among the first agents used to prevent neurocardiogenic syncope and are presumed to work due to their negative inotropic actions that lessen the degree of cardiac mechanoreceptor activation during periods of reduced venous return; however, randomized trials have yielded mixed results and are difficult to compare because of the wide range of methodologies used and the populations studied.51 The recently completed Prevention of Syncope Trial (POST) was a randomized, prospective, placebo-controlled trial of metoprolol versus placebo.52 In patients <42 years of age, metoprolol was no better than placebo; however, in those >42 years of age, the drug produced a significant decline in syncopal events. This would suggest that there may be important age-related differences in response to therapy.

Fludrocortisone is a mineral corticoid that expands fluid volume and increases peripheral α-receptor sensitivity, thus promoting vasoconstriction.53 Although very useful in treating orthostatic hypotension, its use in neurocardiogenic syncope is less well studied.

A variety of vasoconstrictive agents have been used in the treatment of these disorders. The earliest of these were the ephedra alkaloids Dexedrine and methylphenidate, which cause vasoconstriction because of their α-receptor–stimulating actions.54 The related α-1 receptor stimulant midodrine offers a similar degree of vasoconstriction without causing central nervous system stimulation.55 It has been approved by the Food and Drug Administration for treatment of orthostatic hypotension and has proved effective for prevention of neurocardiogenic syncope in 2 randomized trials.56 Yohimbine, ephedrine, and theophylline have also been used; however, poor tolerance often limits their use.57

The α-1 receptor agonist clonidine has been demonstrated to produce a paradoxic increase in blood pressure in autonomic failure patients who have profound postganglionic sympathetic disturbances. In this setting, the vascular postjunctional α-2 receptor density (distributed throughout the vascular system) increases significantly, which results in a hypertensive state. Thus, although clonidine causes the sympathetic system to lower its output and thereby reduce blood pressure in normal subjects, in patients with autonomic failure (who have little or no peripheral sympathetic stimulation), the vasoconstrictive effect of the drug becomes predominant.37 However, the drug must be used with caution, because it may worsen hypotension. Recently, investigators at the Mayo Clinic reported that the acetylcholinesterase inhibitor pyridostigmine was effective in preventing orthostatic hypotension without exacerbating supine hypotension.58 Further randomized trials of this promising agent are now under way.

There is a body of evidence that has demonstrated that serotonin plays an important role in the central nervous system’s regulation of both heart rate and blood pressure.59 In the reflex syncopes, there is thought to be a disturbance in both serotonin production and postsynaptic receptor density that leads to a “hypersensitive” state, characterized by excessive responses to fluctuations in sensory input. The serotonin reuptake inhibitors were explored as a potential therapy because of their ability to downregulate postsynaptic receptor density and thereby blunt the effects of serotonin in mediating sympathetic withdrawal. Several observational studies and one double-blind, randomized, placebo-controlled trial have demonstrated that the serotonin reuptake inhibitors can be remarkably effective in preventing neurocardiogenic syncope and orthostatic hypotension.60–62

It had long been noted that many patients with autonomic failure may also be anemic. Hoeldtke and Streeten63 published a landmark study showing that erythropoietin given via subcutaneous injection could cause significant elevations in blood pressure and increasing blood counts. Subsequent studies have suggested that these effects are independent of each other and that erythropoietin possesses direct vasoconstrictive effects related to its effects on peripheral nitric oxide.64,65

One of the more controversial therapies for neurocardiogenic syncope is permanent cardiac pacing. Some episodes of NCS, both spontaneous and tilt-induced, are associated with profound bradycardia or asystole. The results from early randomized trials suggested that permanent cardiac pacing resulted in a significant reduction in syncopal events.66–68 Concerns were raised about these studies because patients had been randomized to pacing or no pacing, with a possible placebo effect from pacing. To address this point, 2 trials, the Second Vasovagal Pacemaker Study (VPS 2) and the Vasovagal Syncope and Pacing Trial (SYNPACE), implanted permanent pacemakers in groups of patients with recurrent NCS, then randomized them to having the units programmed “on” or “off.”69,70 The VPS study reported there was not a significant difference between the 2 groups after 6 months of follow-up. Interestingly, although the SYNPACE trial showed that there was no significant difference between the 2 groups overall, those patients with asystolic responses during preimplant tilt-table testing had a significant increase in time to syncope recurrence compared with those who had bradycardia alone (91 versus 11 days). At present, we do not recommend permanent pacing as first-line therapy in NCS because the majority of patients will respond to conservative measures and pharmacotherapy. Nonetheless, in those patients with recurrent syncope with little or no prodrome, in whom other forms of therapy are ineffective, permanent pacing may either reduce syncopal frequency or increase the time from onset of symptoms to loss of consciousness.71 This can give the patient a sufficiently long prodrome such that there is time to take evasive actions (ie, lying supine).

The physician should keep in mind that in the autonomic failure syndromes (unlike the reflex syncopes), hypotension is only one aspect of a much more diverse group of symptoms that occur as a consequence of autonomic dysfunction. Some symptoms are easier to treat than others, and one should avoid giving the patient unrealistic expectations. Both the patient and physician should remain cognizant of the fact that some of these disorders are chronic in nature and, in some individuals, may worsen over the course of time. Therefore, treatment plans will need to be reassessed periodically to determine whether they still meet the patient’s changing needs. It is also essential to realize that many patients with the severe forms of autonomic disturbance may have a broad array of personal and social problems that include psychological, marital, occupational, legal, and, frequently, financial problems. Although many physicians feel uncomfortable assisting in these matters, these are the very issues that have the most important influence on patients’ lives. The treating physician should be prepared to assist in helping the patient obtain access to psychologists, social workers, rehabilitation services, and even legal counsel when necessary.72

The attitude of the physician treating the patient with a severe autonomic disorder of any form is of the utmost importance. A positive, yet at the same time realistic, approach by a knowledgeable and sympathetic caregiver can have a significant impact on the patient. Hope is a potent medicine that should be encouraged by all.73

Summary

The ANS is both complex and diverse and is involved in essentially every organ system and in the majority of disease processes. Disruptions in this system can be incredibly diverse in presentation, yet often culminate in a failure to maintain normotension, with resultant near syncope and syncope. A working knowledge of these disorders is required for both their recognition and their management. Further investigations will aid in our understanding of this wide range of disorders and at the same time identify better diagnostic and therapeutic modalities. ⇓

View this table:
  • View inline
  • View popup

TABLE 3. Treatment Options

References

  1. ↵
    Bannister R, Mathias CJ. Introduction and classification of autonomic disorders. In: Mathias C, Bannister R, eds. Autonomic Failure: A Textbook of Clinical Disorders of the Autonomic Nervous System. Oxford, UK: Oxford Press; 1999: xvii–xxii.
  2. ↵
    Calabrese R, Gordon T, Hawkins R, Qian N. Essentials of Neural Science and Behaviour. Norwalk, Conn: Appleton & Lange; 1995.
  3. ↵
    Bennaroch E. The Central Autonomic Network: Functional Organization and Clinical Correlations. Armonk, NY: Futura Press; 1997.
  4. ↵
    Appenzeller O, Oribe E. The Autonomic Nervous System: An Introduction to Basic and Clinical Concepts. Amsterdam, Netherlands: Elsevier Science; 1997.
  5. ↵
    Joyner M, Sheppard T. Autonomic regulation of the circulation. In: Low P, ed. Clinical Autonomic Disorders. 2nd ed. Philadelphia, Pa: Lippincott-Raven; 1997: 61–71.
  6. ↵
    Thompson WO, Thompson PK, Dailey ME. The effect of upright posture on the composition and volume of the blood in man. J Clin Invest. 1988; 5: 573–609.
    OpenUrlCrossRef
  7. ↵
    Wieling W, VanLieshout JJ. Maintenance of postural normotension in humans. In: Low P, ed. Clinical Auton Disord. Philadelphia, Pa: Lippincott-Raven; 1997: 73–82.
  8. ↵
    Streeten D. Physiology of the microcirculation. In: Streeten D, ed. Orthostatic Disorders of the Circulation. New York, NY: Plenum Medical; 1987: 1–12.
  9. ↵
    Mathias C. The classification and nomenclature of autonomic disorders: ending chaos, restoring conflict and hopefully achieving clarity. Clin Auton Res. 1995; 5: 307–310.
    OpenUrlCrossRefPubMed
  10. ↵
    Consensus Committee of the American Autonomic Society and the American Academy of Neurology on the definition of orthostatic hypotension, pure autonomic failure and multiple system atrophy. Neurology. 1996; 46: 1470–1471.
    OpenUrlFREE Full Text
  11. ↵
    Grubb BP. Neurocardiogenic syncope. In: Grubb BP, Olshansky B. Syncope: Mechanisms and Management. Malden, Mass: Blackwell-Futura; 2005: 47–71.
  12. ↵
    Mosqueda-Garcia R, Farlan R, Tank J, Fernandez-Violante R. The elusive pathophysiology of neurally-mediated syncope. Circulation. 2000; 102: 2898–2906.
    OpenUrlFREE Full Text
  13. ↵
    Kosinski D, Grubb BP, Temesy-Armos P. Pathophysiology aspects of neurocardiogenic syncope. Pacing Clin Electrophysiol. 1995; 18: 716–721.
    OpenUrlCrossRefPubMed
  14. ↵
    Morillo CA, Ellenbogen A, Pava LF. Pathophysiologic basis for vasodepressor syncope. In: Klein G, ed. Syncope: Cardiology Clinics of North America. Philadelphia, Pa: Saunders; 1997: 15: 233–250.
  15. ↵
    Sutton R, Peterson M. The clinical spectrum of neurocardiogenic syncope. J Cardiovasc Electrophysiol. 1995; 6: 569–576.
    OpenUrlPubMed
  16. ↵
    Bradbury S, Eggleston C. Postural hypotension: a report of three cases. Am Heart J. 1925; I;73–86.
  17. ↵
    Freeman R. Pure autonomic failure. In: Robertson D, Biaggiona I, eds. Disorders of the Autonomic Nervous System. Luxembourg: Harwood Academic; 1995: 83–106.
  18. ↵
    Low PA, Bannister R. Multiple system atrophy and pure autonomic failure. In: Low P, ed. Clinical Autonomic Disorders. Philadelphia, Pa: Lippincott-Raven; 1997: 555–575.
  19. ↵
    Mathias C, Bannister R. Clinical features and evaluation of the primary chronic autonomic failure syndromes. In: Mathias C, Bannister R, eds. Autonomic Failure: A Textbook of Clinical Disorders of the Autonomic Nervous System. 45th ed. Oxford, UK: Oxford University Press; 1999: 307–320.
  20. ↵
    Schatz IT. Pure autonomic failure. In: Robertson D, Low RA, Polinsky RJ, eds. Primer on the Autonomic Nervous System. San Diego, Calif: Academic Press; 1996: 239–242.
  21. ↵
    Shy GM, Drager GA. A neurologic syndrome associated with orthostatic hypotension. Arch Neural. 1960; 3: 511–527.
    OpenUrl
  22. ↵
    Polinsky RT. Multiple system atrophy and Shy-Drager syndrome. In: Robertson D, Low RA, Polinsky RT, eds. Primer on the Autonomic Nervous System. San Diego, Calif: Academic Press; 1996: 222–226.
  23. ↵
    Fearnley TM, Less AT. Striatonigral degeneration: a clinicopathologic study. Brain. 1990; 113: 1823–1842.
    OpenUrlAbstract/FREE Full Text
  24. ↵
    Hughes AJ, Daniel DE, Kilford L, Lees AJ. Accuracy of clinical diagnosis of idiopathic Parkinson’s disease: a clinico-pathologic study of 100 cases. J Neurol Neurosurg Psychiatr. 1992; 55: 181–184.
    OpenUrlAbstract/FREE Full Text
  25. ↵
    Jellinger KA. Pathology of Parkinson’s disease: changes other than the nigrostriatal pathway. Mol Chem Neuropathol. 1991; 14: 153–197.
    OpenUrlCrossRefPubMed
  26. ↵
    Gilman S, Quinn NP. The relationship of multiple system atrophy to sporadic olivopontocerebellar atrophy and other forms of late onset cerebellar atrophy. Neurology. 1996; 46: 1197–1199.
    OpenUrlFREE Full Text
  27. ↵
    Kanjwal Y, Kosinski D, Grubb BP. The postural tachycardia syndrome: definitions, diagnosis and management. Pacing Clin Electrophysiol. 2003; 26: 1747–1757.
    OpenUrlCrossRefPubMed
  28. ↵
    Grubb BP, Kosinski D, Boehm K, Kip K. The postural tachycardia syndrome: a neurocardiogenic variant identified during head upright tilt table testing. Pacing Clin Electrophysiol. 1997; 20: 2205–2212.
    OpenUrlCrossRefPubMed
  29. ↵
    Low P, Novak Y, Novak P, Sandroni P, Schondorf R, Opfer-Gehrking L. Postural tachycardia syndrome. In: Low P, ed. Clinical Autonomic Disorders. Philadelphia, Pa: Lippincott-Raven; 1997: 681–698.
  30. ↵
    Grubb BP, Calkins H, Rowe P. Postural tachycardia, orthostatic intolerance and chronic fatigue syndrome. In: Grubb B, Olshansky B. Syncope: Mechanisms and Management. Malden, Mass: Blackwell-Futura Press; 2005: 225–244.
  31. ↵
    Shannon J, Flatten NL, Jordan T, Jacob G, Black B, Biaggiona I, Blakely R, Robertson D. Orthostatic intolerance and tachycardia associated with norepinephrine-transporter deficiency. N Engl J Med. 2000; 342: 541–549.
    OpenUrlCrossRefPubMed
  32. ↵
    Grubb BP, Kosinski DJ. Acute pandysautonomic syncope. Eur J Cardiac Pacing Electrophysiol. 1997; 7: 10–14.
    OpenUrl
  33. ↵
    Low P, McLeed T. Autonomic neuropathies. In: Low P, ed. Clinical Autonomic Disorders. Philadelphia, Pa: Lippincott-Raven; 1997: 464–486.
  34. ↵
    Yaki MD, Fronera AT. Acute autonomic neuropathy. Arch Neural. 1975; 32: 132–133.
    OpenUrl
  35. ↵
    Verino S, Low P, Fealy R, Stewart J, Farrujia G., Lennon V. Autoantibodies to ganglionic acetylcholine receptors in autoimmune autonomic neuropathies. N Engl J Med. 2000; 343: 347–355.
    OpenUrl
  36. ↵
    Passant V, Warkentin S, Karlson, Nilsson K, Edvinsson L, Gustafson L. Orthostatic hypotension in organic dementia: relationship between blood pressure, cortical blood flow, and syncope. Clin Auton Res. 1996; 6: 29–36.
    OpenUrlCrossRefPubMed
  37. ↵
    Grubb BP, Kosinski D. Orthostatic hypotension: causes, classification and treatment. Pacing Clin Electrophysiol. 2003; 26: 892–901.
    OpenUrlCrossRefPubMed
  38. ↵
    Sutton R, Benditt D. The basic autonomic assessment. In: Benditt D, Blanc JJ, Brignole M, Sutton R, eds. The Evaluation and Management of Syncope. Malden, Mass: Blackwell-Futura; 2003: 71–79.
  39. ↵
    Grubb BP, Kosinski D. Tilt table testing: concepts and limitations. Pacing Clin Electrophysiol. 1997; 20: 781–787.
    OpenUrlCrossRefPubMed
  40. ↵
    Krahn A, Klein GJ, Yee R, Skanes AC. Randomized assessment of syncope trial: conventional diagnostic testing versus a prolonged monitoring strategy. Circulation. 2001; 104: 46–51.
    OpenUrlAbstract/FREE Full Text
  41. ↵
    Benditt D, Ferguson D, Grubb BP, Kapoor WN, Kugler J, Lerman BB. Tilt table testing for accessing syncope and its treatment: an American College of Cardiology Consensus document. J Am Coll Cardiol. 1996; 28: 263–267.
    OpenUrlCrossRefPubMed
  42. ↵
    Brignole M, Alboni P, Benditt L, Bergfeldt L, Blanc JJ, Bloch Thomsen PE, Fitzpatrick A, Hohnloser S, Kapoor W, Kenny RA, Theodorakis G, Kulakowski P, Moya A, Raviele A, Sutton R, Wieling W, Janousek J, van Dijk G. Guidelines on the management, diagnosis and treatment of syncope. Eur Heart J. 2001; 22: 1256–1306.
    OpenUrlAbstract/FREE Full Text
  43. ↵
    Grubb BP, Samoil D, Kosinski D, Wolfe D, Brewster P, Elliott L, Hahn H. Cerebral syncope: loss of consciousness associated with cerebral vasoconstriction in the absence of systemic hypotension. Pacing Clin Electrophysiol. 1988; 21: 652–658.
    OpenUrlCrossRef
  44. ↵
    Grubb BP, Gerard G, Wolfe DA, Samoil D, Davenport CW, Homan RW. Syncope and seizure of psychogenic origin: identification with head upright tilt table testing. Clin Cardiol. 1992; 15: 839–842.
    OpenUrlCrossRefPubMed
  45. ↵
    Kouakam C, Lacriox D, Klug D, Baux P, Marquie C, Kacet S. Prevalence and significance of psychiatric disorders in patients evaluated for recurrent neurocardiogenic syncope. Am J Cardiol. 2002; 89: 530–535.
    OpenUrlCrossRefPubMed
  46. ↵
    Ector H, Reybrouck T, Heidbuchel H, Gewillig M, Van de Werf F. Tilt training: a new treatment for recurrent neurocardiogenic syncope or severe orthostatic intolerance. Pacing Clin Electrophysiol. 1998; 21: 193–196.
    OpenUrlCrossRefPubMed
  47. ↵
    Di Girolamo E, Di Iorio C, Leonzio L, Sabatini P, Barsotti A. usefulness of a tilt training program for the prevention of refractory neurocardiogenic syncope in adolescents: a controlled study. Circulation. 1999; 100: 1798–1801.
    OpenUrlAbstract/FREE Full Text
  48. ↵
    Abe H, Kondo S, Kohshi K, Nakashima Y. Usefulness of orthostatic self-training for the prevention of neurocardiogenic syncope. Pacing Clin Electrophysiol. 2002; 25: 1454–1458.
    OpenUrlCrossRefPubMed
  49. ↵
    Brignole M, Croci F, Menozzi C, Solano A, Donateo P, Oddone D, Puggioni E, Lolli G. Isometric arm counter-pressure maneuvers to abort impending vasovagal syncope. J Am Coll Cardiol. 2002; 40: 2054–2060.
    OpenUrl
  50. ↵
    Krediet P, van Dijk N, Linzer M. Lieshout J, Wieling W. Management of vasovagal syncope: controlling or aborting faints by leg crossing and muscle tensing. Circulation. 2002; 106: 1684–1689.
    OpenUrlAbstract/FREE Full Text
  51. ↵
    Brignole M. Randomized trials of neurally mediated syncope. J Cardiovasc Electrophysiol. 2003; 14: 564–569.
    OpenUrl
  52. ↵
    Sheldon R. The Prevention of Syncope (POST) results. Paper presented at: Late Breaking Trials Heart Rhythm Society Meeting; May 22, 2004; San Francisco, Calif.
  53. ↵
    Hickler RB, Thompson GR, Fox LM, Hamlin JT. Successful treatment of orthostatic hypotension with 9-X-fluohydrocortisone. N Engl J Med. 1959; 261: 788–791.
    OpenUrlPubMed
  54. ↵
    Grubb BP, Kosinski D, Mouhaffel A, Pothoulakis A. Utility of methylphenidate in the therapy of refractory neurocardiogenic syncope. Pacing Clin Electrophysiol. 1996; 19: 836–840.
    OpenUrlCrossRefPubMed
  55. ↵
    McTavish D, Goa KL. Midodrine: a review of its pharmacologic properties and therapeutic use in orthostatic hypotension and secondary hypotensive disorders. Drugs. 1989; 38: 757–777.
    OpenUrlCrossRefPubMed
  56. ↵
    Jankovic J, Gilden JL, Hiner BC, Kaufman H, Brown DC, Coghlan CH, Rubin M, Fouad-Tarazi FM. Neurocardiogenic orthostatic hypotension: a double blind placebo controlled study with midodrine. Am J Med. 1993; 95: 38–48.
    OpenUrlCrossRefPubMed
  57. ↵
    Goldberg MR, Hollister AS, Robertson D. Influence of yohimbine on blood pressure, autonomic reflexes, and plasma catecholamines in humans. Hypertension. 1983; 5: 772–778.
    OpenUrlAbstract/FREE Full Text
  58. ↵
    Singer W, Opfen-Gehrking, McPhee BR, Hiltz MJ, Bharucha AE, Low P. Acetylcholinesterase inhibition: a novel approach in the treatment of orthostatic hypotension. J Neurol Neurosurg Psychiatry. 2003; 74: 1294–1298.
    OpenUrlAbstract/FREE Full Text
  59. ↵
    Grubb BP, Karas BJ. The potential role of serotonin in the pathogenesis of neurocardiogenic syncope and related autonomic disturbances. J Intervent Cardiac Electrophysiol. 1998; 2: 325–332.
    OpenUrlCrossRefPubMed
  60. ↵
    Grubb BP, Samoil D, Kosinski D, Wolfe D, Lorton M, Madu E. Fluoxetine hydrochloride for the treatment of severe refractory orthostatic hypotension. Am J Med. 1994; 97: 366–368.
    OpenUrlCrossRefPubMed
  61. ↵
    Di Gerolamo E, Di Iorio C, Sabatini O, Leonzio L, Barbone C, Barsotti A. Effects of paroxetine hydrochloride, a selective serotonin reuptake inhibitor, on refractory vasovagal syncope: a randomized, double-blind, placebo-controlled study. J Am Coll Cardiol. 1999; 33: 1227–1230.
    OpenUrlCrossRefPubMed
  62. ↵
    Grubb BP, Kosinski D. Preliminary observations on the use of venlafaxine hydrochloride in refractory orthostatic hypotension. J Serotonin Res. 1996; 6: 89–94.
    OpenUrl
  63. ↵
    Hoeldkte RD, Streeten DH. Treatment of orthostatic hypotension with erythropoietin. N Engl J Med. 1993; 329: 611–615.
    OpenUrlCrossRefPubMed
  64. ↵
    Biaggioni S, Robertson D, Krantz S, Jones M, Hale V. The anemia of primary autonomic failure and its reversal with recombinant erythropoietin. Ann Intern Med. 1994; 121: 181–186.
    OpenUrlPubMed
  65. ↵
    Grubb BP, Lachant N, Kosinski D. Erythropoietin as a therapy for severe refractory orthostatic hypotension. Clin Auton Res. 1994; 4: 212. Abstract.
    OpenUrl
  66. ↵
    Connolly SJ, Sheldon R, Roberts RS, Gent M. The North American Vasovagal Pacemaker Study (VPS): a randomized trial of permanent cardiac pacing for the prevention of vasovagal syncope. J Am Coll Cardiol. 1999; 33: 16–20.
    OpenUrlCrossRefPubMed
  67. ↵
    Sutton R, Brignole M, Menozzi C, Raviele A, Alboni P, Giani P, Moya A. Dual-chamber pacing in the treatment of neurally mediated tilt-positive cardioinhibitory syncope: pacemaker versus no therapy: a multicenter randomized study. Circulation. 2000; 102: 294–299.
    OpenUrlAbstract/FREE Full Text
  68. ↵
    Ammirati F, Colivicchi F, Santini M. Permanent cardiac pacing vs. medical treatment for the prevention of recurrent vasovagal syncope: a multicenter, randomized, controlled trial. Circulation. 2001; 104: 52–57.
    OpenUrlAbstract/FREE Full Text
  69. ↵
    Connolly SJ, Sheldon R, Thorpe KE, Roberts RS, Ellenbogen KA, Wilkoff BL, Morillo C, Gent M, for the VPS II Investigators. Pacemaker therapy for prevention of syncope in patients with recurrent severe vasovagal syncope: Second Vasovagal Pacemaker Study (VPS II). JAMA. 2003; 289: 2224–2229.
    OpenUrlCrossRefPubMed
  70. ↵
    Giada F, Raviele A, Menozzi C, Speca G, Grazi S, Gasparini G, Sutton R. The vasovagal syncope and pacing trial (Synpace): a randomized placebo-controlled study of permanent pacing for treatment of recurrent vasovagal syncope. Pacing Clin Electrophysiol. 2003; 26: 1016. Abstract.
    OpenUrl
  71. ↵
    Sutton K. Has cardiac pacing a role in vasovagal syncope? J Intervent Cardiovasc Electrophysiol. 2003; 9: 145–149.
    OpenUrlCrossRef
  72. ↵
    Li J. The physician as advocate. Mayo Clinic Proc. 1998; 73: 1022–1024.
    OpenUrlCrossRefPubMed
  73. ↵
    Li J. Hope and the medical encounter. Mayo Clinic Proc. 2000; 75: 765–767.
    OpenUrlCrossRefPubMed
View Abstract
Back to top
Previous ArticleNext Article

This Issue

Circulation
June 7, 2005, Volume 111, Issue 22
  • Table of Contents
Previous ArticleNext Article

Jump to

  • Article
    • Autonomic Nervous System
    • Summary
    • References
  • Figures & Tables
  • Info & Metrics
  • eLetters

Article Tools

  • Print
  • Citation Tools
    Neurocardiogenic Syncope and Related Disorders of Orthostatic Intolerance
    Blair P. Grubb
    Circulation. 2005;111:2997-3006, originally published June 6, 2005
    https://doi.org/10.1161/CIRCULATIONAHA.104.482018

    Citation Manager Formats

    • BibTeX
    • Bookends
    • EasyBib
    • EndNote (tagged)
    • EndNote 8 (xml)
    • Medlars
    • Mendeley
    • Papers
    • RefWorks Tagged
    • Ref Manager
    • RIS
    • Zotero
  •  Download Powerpoint
  • Article Alerts
    Log in to Email Alerts with your email address.
  • Save to my folders

Share this Article

  • Email

    Thank you for your interest in spreading the word on Circulation.

    NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

    Enter multiple addresses on separate lines or separate them with commas.
    Neurocardiogenic Syncope and Related Disorders of Orthostatic Intolerance
    (Your Name) has sent you a message from Circulation
    (Your Name) thought you would like to see the Circulation web site.
  • Share on Social Media
    Neurocardiogenic Syncope and Related Disorders of Orthostatic Intolerance
    Blair P. Grubb
    Circulation. 2005;111:2997-3006, originally published June 6, 2005
    https://doi.org/10.1161/CIRCULATIONAHA.104.482018
    del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo

Related Articles

Cited By...

Subjects

  • Cardiology
    • Etiology
      • Arrhythmias, clinical electrophysiology, drugs
  • Arrhythmia and Electrophysiology
    • Arrhythmias

Circulation

  • About Circulation
  • Instructions for Authors
  • Circulation CME
  • Statements and Guidelines
  • Meeting Abstracts
  • Permissions
  • Journal Policies
  • Email Alerts
  • Open Access Information
  • AHA Journals RSS
  • AHA Newsroom

Editorial Office Address:
200 Fifth Avenue, Suite 1020
Waltham, MA 02451
email: circ@circulationjournal.org
 

Information for:
  • Advertisers
  • Subscribers
  • Subscriber Help
  • Institutions / Librarians
  • Institutional Subscriptions FAQ
  • International Users
American Heart Association Learn and Live
National Center
7272 Greenville Ave.
Dallas, TX 75231

Customer Service

  • 1-800-AHA-USA-1
  • 1-800-242-8721
  • Local Info
  • Contact Us

About Us

Our mission is to build healthier lives, free of cardiovascular diseases and stroke. That single purpose drives all we do. The need for our work is beyond question. Find Out More about the American Heart Association

  • Careers
  • SHOP
  • Latest Heart and Stroke News
  • AHA/ASA Media Newsroom

Our Sites

  • American Heart Association
  • American Stroke Association
  • For Professionals
  • More Sites

Take Action

  • Advocate
  • Donate
  • Planned Giving
  • Volunteer

Online Communities

  • AFib Support
  • Garden Community
  • Patient Support Network
  • Professional Online Network

Follow Us:

  • Follow Circulation on Twitter
  • Visit Circulation on Facebook
  • Follow Circulation on Google Plus
  • Follow Circulation on Instagram
  • Follow Circulation on Pinterest
  • Follow Circulation on YouTube
  • Rss Feeds
  • Privacy Policy
  • Copyright
  • Ethics Policy
  • Conflict of Interest Policy
  • Linking Policy
  • Diversity
  • Careers

©2018 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. The American Heart Association is a qualified 501(c)(3) tax-exempt organization.
*Red Dress™ DHHS, Go Red™ AHA; National Wear Red Day ® is a registered trademark.

  • PUTTING PATIENTS FIRST National Health Council Standards of Excellence Certification Program
  • BBB Accredited Charity
  • Comodo Secured